The Patent Finder

Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy

Avidity Biosciences, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 10 of these applications claim priority to application PCT/US2018/064359, filed Dec 6, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,881,743Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy
In force
 · Medium confidence
UsedRemaining
Avidity Biosciences LLCIn forceMedium confidence
US 11,246,941Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy
In force
 · Medium confidence
Avidity Biosciences, Inc.In forceMedium confidence
US 11,253,607Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy
In force
 · Medium confidence
Avidity Biosciences, Inc.In forceMedium confidence
US 11,497,814Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy
In force
 · Low confidence
Avidity Biosciences, Inc.In forceLow confidence
US 11,554,176Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy
In force
 · Low confidence
Avidity Biosciences, Inc.In forceLow confidence
US 11,576,980Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy
In force
 · Low confidence
Avidity Biosciences, Inc.In forceLow confidence
US 11,583,591Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy
In force
 · Low confidence
Avidity Biosciences, Inc.In forceLow confidence
US 11,872,287Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy
In force
 · Low confidence
Avidity Biosciences, Inc.In forceLow confidence
US 12,263,224Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy
In force
 · High confidence
Avidity Biosciences, Inc.In forceHigh confidence
US 11,712,478Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy
In force
 · Medium confidence
Avidity Biosciences, Inc.In forceMedium confidence
4 more records in this group · Pro
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14.
Upgrade to Pro
10 of these are in force and held by Avidity Biosciences, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited